Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.23.01502
PubMed Identifier: 37847874
Publication URI: http://europepmc.org/abstract/MED/37847874
Type: Journal Article/Review
Volume: 41
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 36
ISSN: 0732-183X